We are live on
!
Find out more
VCM
Violich Capital Management Portfolio holdings
AUM
$919M
1-Year Est. Return
40.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.73%
1 Year Est. Return
+40.7%
3 Year Est. Return
+100.28%
5 Year Est. Return
+135.3%
10 Year Est. Return
+480.06%
AUM
$331M
AUM Growth
+$5.09M
(+1.6%)
Cap. Flow
-$3.61M
Cap. Flow
% of AUM
-1.09%
Top 10 Holdings %
Top 10 Hldgs %
41.03%
Holding
115
New
2
Increased
23
Reduced
35
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Maximus
MMS
|
+$205K |
| 2 |
AYR
Aircastle Ltd
AYR
|
+$200K |
| 3 |
Nike
NKE
|
+$177K |
| 4 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$125K |
| 5 |
PX
Praxair Inc
PX
|
+$124K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.62M |
| 2 |
ANI Pharmaceuticals
ANIP
|
+$255K |
| 3 |
SLB Ltd
SLB
|
+$251K |
| 4 |
Medtronic
MDT
|
+$225K |
| 5 |
Vanguard Long-Term Bond ETF
BLV
|
+$209K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 20.68% |
| 3 | Financials | 13.24% |
| 4 | Communication Services | 11.72% |
| 5 | Consumer Staples | 10.89% |
Similar funds
AIA
FFL
TCM
SC
KI
BDF
GFG
OWIM
Violich Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Violich Capital Management held 115 positions worth $331M, up 1.6% from $326M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Violich Capital Management's Q1 2017 filing shows 2 new, 23 increased, 35 reduced and 5 closed positions. Its largest new stake was Maximus: 3,490 shares worth $217K. The largest sale was Apple, an estimated $2.62M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Violich Capital Management's largest Q1 2017 buy was Maximus: 3,490 shares worth $217K.
- Violich Capital Management added most to Nike in Q1 2017, an estimated $177K increase.
- Violich Capital Management's biggest Q1 2017 reduction was Apple, cutting an estimated $2.62M.
- Violich Capital Management fully exited ANI Pharmaceuticals in Q1 2017, selling an estimated $255K.
- Violich Capital Management's ten largest holdings make up 41% of its $331M portfolio in Q1 2017.
- Violich Capital Management opened 2 new positions and closed 5 in Q1 2017.
- Violich Capital Management's portfolio value rose 1.6% quarter-over-quarter to $331M.
Based on Violich Capital Management's 13F filing for Q1 2017, filed 11 May 2017.